Filtered By:
Drug: Abatacept
Countries: South Korea Health
This page shows you your search results in order of date.
Order by Relevance | Date
Total 4 results found since Jan 2013.
Baseline use of hydroxychloroquine or immunosuppressive drugs and the risk of coronavirus disease 2019
CONCLUSIONS: The risk of COVID-19 did not differ between HCQ users and non-users. Glucocorticoids, conventional disease-modifying antirheumatic drugs (DMARDs), and biological DMARDs other than abatacept did not increase the risk of COVID-19.PMID:33706472 | DOI:10.3904/kjim.2020.633
Source: The Korean Journal of Internal Medicine - March 12, 2021 Category: Internal Medicine Authors: Ji-Won Kim Sang Gyu Kwak Hwajeong Lee Seong-Kyu Kim Jung-Yoon Choe Sung-Hoon Park Source Type: research
